摘要
目的探讨质子泵抑制剂药动学相互作用的研究进展。方法对国内外相关领域的文献进行归纳和总结。结果系统地对质子泵抑制剂通过提高胃内pH值和抑制P-糖蛋白影响相关药物吸收,抑制CYP2C19和CYP3A4影响相关药物代谢,抑制相关药物经肾清除等进行阐述。重点介绍了质子泵抑制剂与地高辛、伊曲康唑、酪氨酸激酶抑制剂、氯吡格雷、华法林、甲氨蝶呤、顺铂和培美曲塞的相互作用。结论临床用药应密切关注药物相互作用,避免质子泵抑制剂与此类药物联合使用或选用相互作用较小的质子泵抑制剂。
OBJECTIVE To explore the progress of proton pump inhibitors pharmacokinetic interactions. METHODS To analyze and summarize the domestic and oversea research in the related area. RESULTS It systematically expounded that proton pump inhibitors affect the absorption of related drugs by increasing the pH in the stomach and inhibiting P-glycoprotein, and affect the metabolism of related drugs by inhibiting CYP2 C19 and CYP3 A4, and inhibiting the removal of related drugs by the kidney. The focus was on the interaction of proton pump inhibitors with digoxin, itraconazole, tyrosine kinase inhibitors, clopidogrel, warfarin, methotrexate, cisplatin and pemetrexed. CONCLUSION It should pay close attention to drug-drug interactions in clinical medication, and avoid the use of proton pump inhibitors in combination with such drugs, or select the proton pump inhibitors with lower interaction.
作者
王巧红
张雅兰
梁翠绿
张吟
WANG Qiaohong;ZHANG Yalan;LIANG Cuilyu;ZHANG Yin(Department of Pharmacy,The Second Affiliated Hospital of Fujian Medical University,Quanzhou 362000,China;College of Pharmacy,Fujian Medical University,Fuzhou 350000,China)
出处
《中国现代应用药学》
CAS
CSCD
北大核心
2021年第9期1140-1147,共8页
Chinese Journal of Modern Applied Pharmacy
基金
泉州市科技计划项目(2017Z012)。
关键词
质子泵抑制剂
药物相互作用
药动学
地高辛
氯吡格雷
甲氨蝶呤
proton pump inhibitors
drug-drug interaction
pharmacokinetics
digoxin
clopidogrel
methotrexate
